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Appendix 1: Definitions used for assessing the risk of bias in individual randomised controlled trials.
Domain

Risk of bias Definition Sequence generation
Low -Random number 
Low
-Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken -Either participants or some key personnel were not blinded but outcome assessment was blinded and the non-blinding of others unlikely to introduce bias High -No blinding or incomplete blinding and the outcome measurement is likely to be influenced by lack of blinding (i.e., subjective outcome) -Blinding of participants and personnel attempted but likely that the blinding could have been broken (differences in co-interventions among groups) -Either participants or personnel were not blinded, and the non-blinding likely to introduce bias Unclear -Insufficient information to permit judgement of "low risk" or "high risk" -Insufficient information about co-interventions to assess whether lack of blinding or incomplete blinding was likely to influence the outcome Blinding of outcome assessment
-No blinding but objective outcome (i.e., mortality, biological tests) -Blinding of outcome assessor and unlikely that the blinding could have been broken High -No blinding or incomplete blinding and the outcome measurement is likely to be influenced by lack of blinding (i.e., subjective outcome) -Blinding of outcome assessment, but likely that the blinding could have been broken, and the outcome measurement is likely to be influenced by lack of blinding Unclear -Insufficient information regarding outcome assessment blinding Incomplete outcome data Low -No missing outcome data -Missing data have been imputed using appropriate methods (worst-case analysis) -Missing data balanced in numbers across intervention groups with similar reasons for missing data across groups -The proportion of missing outcomes compared with observed event risk not enough to have a clinically relevant impact on the intervention effect estimate (< 10% of the number of patients randomised or < the number of outcomes) High -Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing data across intervention groups -The proportion of missing outcomes compared with observed event risk enough to induce clinically relevant bias in intervention effect estimate (≥ 10% of patients randomised or ≥ the number of outcomes) -As-treated analysis performed with substantial departure of the intervention received from that assigned at randomisation (≥ 10% of patients randomised or ≥ the number of outcomes) Unclear -Insufficient reporting of attrition/exclusion (i.e., number of participants randomised and analysed not stated, no reason for missing data provided)
